Document is current
Any future updates will be listed below
-
Authors
Passini, Elisa https://orcid.org/0000-0003-0116-6347
Adedeji, Adeyemi O.
Allen, Romalie
Baldrick, Paul
Basak, Jayati
Britton, Lorraine
Cotton, Peter
Harding, Joanna
Holmes, Thomas
Ljumanovic, Nina
McClure, Fiona
McGuire, Aidan
McInnes, Liz
Prior, Helen
Sewell, Fiona
-
Funding
Funding for this research was provided by:
The Association of the British Pharmaceutical Industry
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 16 January 2025
First Online: 6 February 2025
Declarations
:
: No animal studies were conducted for this publication. All the animal studies reviewed/mentioned were previously conducted for other purposes. All applicable international, national and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. GSK is committed to the replacement, reduction and refinement of animal studies (3Rs). Non-animal models and alternative technologies are part of their strategy and employed where possible. When animals are required, application of robust study design principles and peer review minimises animal use, reduces harm and improves benefit in studies.
: For this type of study, informed consent is not required.
: For this type of study, consent for publication is not required.
: The authors declare no competing interests.
